The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?

Direct-to-toxicology viral vector services

Fact Sheet

Toxicology studies are crucial for supporting pre-IND regulatory requirements and evaluating the risk-benefit ratio of drug candidates. However, acquiring high-quality toxicology materials can often stretch timelines, and the incompatibility between toxicology materials generation processes and current good manufacturing practice regulations can impede smooth transitions. Our direct-to-toxicology viral vector services program expedites the route to toxicology materials through our adeno-associated virus (AAV) and lentivirus (LV) production processes, completing them in as little as six months.